Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close
systematic literature review process

How to Do an AI-Assisted Systematic Literature Review: A Step-by-Step Guide

BlogMay 14, 2026104Views0Likes0Comments
The Systematic Literature Review Definition: Systematic Literature Review (SLR) is a rigorous, structured, and transparent process of identifying, analyzing, and synthesizing all existing research on a clearly defined question or topic, providing a comprehensive summary and critical evaluation of the evidence. If you’ve ever tried to pull together evidence for a big research question, you’ll…

Read More

AI Agents Transform Regulatory Content

2026 Prediction #6: AI Agents Will Transform Regulatory Content into a Competitive Asset

BlogApril 28, 202661Views0Likes0Comments
Introduction: The Next Wave of Pharma Innovation In the life sciences, regulatory content has always played a critical role, yet it has rarely been treated as a strategic asset. Documents such as clinical summaries, regulatory submissions, safety reports, and evidence dossiers are essential for compliance, but they are often viewed as static outputs rather than…

Read More

MadeAi | How Agentic AI is Revolutionizing Pharma’s Continuous Evidence Generation in 2026

How Agentic AI is Revolutionizing Pharma’s Continuous Evidence Generation in 2026

BlogMarch 31, 2026116Views0Likes0Comments
For years, the pharmaceutical industry has followed a familiar cycle: design a clinical trial, execute it, lock the database, analyze the results, and then wait for the next study to answer remaining questions. Wait for post-market surveillance to show real-world outcomes. Wait for regulators or payers to request more data before approving reimbursement. However, this…

Read More

MadeAi | 2026 Prediction #3: Role-Based Tool Isolation: The Gold Standard for Secure Pharma AI

2026 Prediction #3: Role-Based Tool Isolation: The Gold Standard for Secure Pharma AI

BlogMarch 25, 202688Views0Likes0Comments
The pharmaceutical industry is currently at a pivotal moment in the AI landscape. After years of cautious AI experimentation limited to isolated labs and pilot programs, something fundamentally different is unfolding in 2026. The central question has shifted from “Does AI work?” to “How do we deploy it safely and at scale?” especially in organizations…

Read More